Lumida
/AMBQ
⌘K
AMBQ

AMBQ

AMBQ
$72.43USD↓-2.73%-2.03 today

MARKET CAP

1.7B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$66 – $74

52W RANGE

$22
$92

AI Summary

Stalk
Sell NowMedium

AMBQ is in a confirmed Stage 4 decline with lower highs and lower lows, trading below short-term EMAs which are declining, confirming medium-term bearish control. Short-term trend is down with no exhaustion signals, favoring immediate downside participation. The long-term uptrend remains intact but is overshadowed by the intermediate decline phase.

  • ↑Q1 net sales surged 59.3% YoY to $25.1M; Q2 guidance targets ~75% growth.
  • ↑Gross profit jumped 56.2% YoY to $11.6M; non-GAAP gross margin up 210bps.
  • ↓Q1 net loss of $0.25 per share highlights ongoing unprofitability.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Ambiq Micro, Inc. (NYSE: AMBQ) is a leading player in the ultra-low power semiconductor market, specializing in innovative solutions for edge AI applications. The company's core offerings focus on energy-efficient microcontrollers and systems-on-chip designed to enhance performance across a variety of domains, including healthcare, smart home devices, and industrial applications. This positions Ambiq Micro strongly within the rapidly expanding edge AI market, enabling devices to perform advanced computations locally and thereby reducing latency and enhancing user experience.

Bull says

  • ↑Q1 net sales surged 59.3% YoY to $25.1M; Q2 guidance targets ~75% growth.
  • ↑Gross profit jumped 56.2% YoY to $11.6M; non-GAAP gross margin up 210bps.
  • ↑Cash balance of $204.5M provides flexibility for product innovation and scaling.
  • ↑Top-three customer concentration fell to 71% from 86%, diversifying revenue base.
  • ↑HeliaCORE launch taps edge AI demand across healthcare, smart home, industrial sectors.
  • ↑Analysts’ $84 average price target implies double-digit upside from current levels.

Bear says

  • ↓Q1 net loss of $0.25 per share highlights ongoing unprofitability.
  • ↓Non-GAAP operating expenses projected at $85M for the year pressure margins.
  • ↓71% of revenue tied to top-three customers, exposing concentration risk.
  • ↓Supply-chain disruptions and rising input costs could erode future margins.
  • ↓Low earnings yield and weak profitability factors indicate potential overvaluation.
  • ↓High share volatility and low institutional ownership may deter risk-averse investors.

Earnings Call · Q4 2025 · Mgmt. Guidance

Updated 04-09-2026bullish

Transcript signals

Bull points

  • Our full year results reflect stronger margins and increased gross profit dollars by 32.1% on 4.7% lower net sales, achieving our highest ever annual gross profit.
  • We delivered the highest net sales quarter of 2025 with results ahead of our guidance on accelerating demand trends.
  • For the first quarter of 2026, we expect net sales to be in the range of $21 million to $22 million, reflecting the trends Hume covered earlier.

Bear points

  • non-GAAP net loss attributable to common stockholders was $5.9 million, a $1.7 million improvement year over year, and $1.9 million lower sequentially.
  • Non-GAAP net loss per share attributable to common stockholders was $0.32.
  • Increasing cost of being a fabulous semiconductor company exposes us to higher costs pricing of our capacity probably more in the second half of the year. So that aspect of it, we're monitoring very closely and that could put pressure on our ability to grow margins year over year.
Read full transcript analysis ›